In Reply to Rodgers.

Acad Med

Associate professor of pediatrics, Emory School of Medicine, Atlanta, GeorgiaORCID: https://orcid.org/0000-0002-3145-5791 .

Published: March 2023

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACM.0000000000005109DOI Listing

Publication Analysis

Top Keywords

reply rodgers
4
reply
1

Similar Publications

Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation.

J Clin Oncol

January 2025

George M. Rodgers, MD, PhD, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; and Jeffrey A. Gilreath, PharmD, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, Department of Pharmacy, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

View Article and Find Full Text PDF

In Reply to Rodgers.

Acad Med

March 2023

Associate professor of pediatrics, Emory School of Medicine, Atlanta, GeorgiaORCID: https://orcid.org/0000-0002-3145-5791 .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!